CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE406.055.45 (+1.36 %)
PREV CLOSE ( ) 400.60
OPEN PRICE ( ) 397.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 406.05 (186)
VOLUME 46008
TODAY'S LOW / HIGH ( )397.00 408.50
52 WK LOW / HIGH ( )373.05 558
NSE406.555.9 (+1.47 %)
PREV CLOSE( ) 400.65
OPEN PRICE ( ) 400.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 406.55 (861)
VOLUME 618503
TODAY'S LOW / HIGH( ) 399.90 408.95
52 WK LOW / HIGH ( )378.55 560
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Formulation Units,Zydus Tower,Satellite Cross Roads,
Ahmedabad,
Gujarat-380015

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX
NEWS
12Feb ONGC, Cadila Healthcare and Dredging C
ONGC’s international arm - ONGC Videsh (OVL) led Indian consortium has b..
12Feb Cadila Healthcare advances on completi
Cadila Healthcare is currently trading at Rs. 421.65, up by 10.60 points..
10Feb Cadila Healthcare completes USFDA insp
Cadila Healthcare has successfully completed the US Food and Drug Admini..
08Feb Cadila Healthcare’s Q3 consolidated ne
Cadila Healthcare has reported results for third quarter ended December..
08Feb Cadila Healthcare trades jubilantly on
Cadila Healthcare is currently trading at Rs. 413.40, up by 17.10 points..
Financials
Rs. in Millions
QTR Dec 17 ANNUAL 17
Net Profit30646619
Gross Profit 3867 6422
Operating Profit 46729042
Net Sales 1573832745
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2169.25 (2.26%)
M.Cap (Rs. in Cr)35986.45
Merck (BSE)
 1486.60 (2.96%)
M.Cap (Rs. in Cr)2467.66
Abbott India (BSE)
 5788.40 (0.72%)
M.Cap (Rs. in Cr)12299.95
Zandu Realty (BSE)
 1993.80 (1.95%)
M.Cap (Rs. in Cr)160.78
Piramal Enterprises (BSE)
 2622.05 (1.31%)
M.Cap (Rs. in Cr)47275.73
Shareholding Pattern
PROMOTERS 74.79%
NON-INSTITUTION 8.28%
MUTUAL FUNDS/UTI 4.15%
FI/BANKS/INSURANCE 3.65%
GOVERNMENT 0.17%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.